Inventor · disambiguated record
Eric Mull
Also filed as: MULL ERIC · MULL ERIC S
25 granted patents·7 pending applications·204 citations·filing 2002–2020
95Inventor score
Files withBRISTOL MYERS SQUIBB CO20BAYER PHARMACEUTICALS CORP6WANG TAO3BAYER PHARMACEUTICLAS CORP1HIEBERT SHELDON1
Top patents by PatentIndex Score
32 records- 0197US9732119B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Aug 15, 2017·14 cites·8 claims
- 0296US9308236B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 12, 2016·51 cites·5 claims
- 0395US9879046B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 30, 2018·17 cites·12 claims
- 0493US10143746B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·9 cites·17 claims
- 0592US9850283B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 26, 2017·12 cites·1 claims
- 0692US8445490B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2011·Granted May 21, 2013·11 cites·2 claims
- 0788US9944678B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 17, 2018·8 cites·2 claims
- 0887US10450347B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 22, 2019·6 cites·23 claims
- 0987US10358463B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 23, 2019·7 cites·15 claims
- 1087US10144706B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 4, 2018·7 cites·8 claims
- 1185US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 1284US10538555B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 21, 2020·8 cites·3 claims
- 1384US8765944B2Compounds for the treatment of hepatitis CSUN LI-QIANG·Filed 2011·Granted Jul 1, 2014·7 cites·9 claims
- 1483US8586584B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2010·Granted Nov 19, 2013·7 cites·15 claims
- 1582US11066445B2Immunomodulators acting as antagonists of PD-1BRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 20, 2021·2 cites·6 claims
- 1679US10745382B2Compounds useful as immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Aug 18, 2020·2 cites·25 claims
- 1778US8741884B2Compounds for the treatment of hepatitis CWANG TAO·Filed 2011·Granted Jun 3, 2014·4 cites·15 claims
- 1876US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 1975US8957203B2Hepatitis C virus inhibitorsHIEBERT SHELDON·Filed 2012·Granted Feb 17, 2015·4 cites·3 claims
- 2072US10745384B2Indazole derivatives as αv integrin antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 18, 2020·1 cites·18 claims
- 2166US9527885B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 27, 2016·1 cites·8 claims
- 2259US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 2357US2017369530A1Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2455US11028071B2Indazole derivatives as alpha v integrin antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 8, 2021·0 cites·12 claims
- 2546US9624245B2Macrocyclic compounds as HCV entry inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 18, 2017·0 cites·3 claims
- 2646US2006063760A1Hydroxamic acids useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 2745US9598433B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 21, 2017·0 cites·6 claims
- 2844US2009247590A1Indane amidesBAYER PHARMACEUTICLAS CORP·Filed 2005·Application pending·0 cites
- 2944US2016222060A1ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3043US2009258888A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3142US2006009483A1Compounds and compositions for the treatment of diabetes and diabetes-related disordersBAYER PHARMACEUTICALS CORP·Filed 2003·Application pending·0 cites
- 3240US9499550B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Nov 22, 2016·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Eric Mull files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →